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ABSTRACT
A rapid and green procedure has been introduced for the preparation of tetrahydrochromeno[4,3-b]chromene-6,8-dione derivatives
in the presence of magnesium perchlorate. This solvent-free procedure offers some advantages such as short reaction times, high
yields, an easy-to-handle catalyst, and avoidance of organic solvents. In this work four new compounds are reported.
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1. Introduction
Multi-component reactions (MCRs), involving three or more
reactants in one pot, have been used to synthesize structurally
diverse bioactive heterocyclic compounds.1 A number of tetra-
hydrochromeno[4,3-b]chromene-6,8-dione derivatives have
been synthesized utilizing one-pot three-component reac-
tions.2–6 There are a few reports on coupling of 4-hydroxy-
coumarin, aldehydes, and cyclic 1,3-diketone compounds.7–10
However, these methods for preparing tetrahydrochromeno
[4,3-b]chromene-6,8-dione derivatives have not been entirely
satisfactory and involve some disadvantages such as long reac-
tion times and use of organic solvents. Magnesium perchlorate
[Mg(ClO4)2] is a non-toxic, cheap, commercially available,
moisture stable white crystal. In continuation of our research on
the applications of solid acids in organic synthesis,11 it was found
interesting to develop a green and more general protocol for the
efficient one-pot three-component synthesis of tetrahydrochro-
meno[4,3-b]chromene-6,8-dione derivatives in the presence
of Mg(ClO4)2.
2. Results and Discussion
The 10,10-dimethyl-7-phenyl-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione was synthesized by the condensa-
tion of 4-hydroxycoumarin, 5,5-dimethyl-1,3-cyclohexanedione
(dimedone) and benzaldehyde in the presence of Mg(ClO4)2 as
a catalyst. Initially, we explored the catalytic efficiency
of Mg(ClO4)2 and the other Lewis acids such as MgSO4, MgBr2,
MgCl2, and LiClO4. However, MgSO4, MgBr2, and LiClO4 did not
exhibit any significant catalytic activity, and only a 70% yield
was obtained in the presence of MgCl2. This establishes the fact
that amongst the various salts used, Mg(ClO4)2 was the most
effective catalyst for the synthesis of 10,10-dimethyl-7-phenyl-
10,11-dihydrochromeno[4,3-b]chromene-6,8(7H,9H)-dione. To
optimize the reaction conditions, dimedone 1 (1 mmol),
4-hydroxycoumarin 2 (1 mmol) and benzaldehyde 3 (1 mmol)
were used in the presence of Mg(ClO4)2 under different condi-
tions. We found that using a 0.04 g (0.18 mmol) catalyst at 90 °C
in solvent-free conditions gave optimum results (Table 1, Entries
7, 10–14). We also observed that, besides 4a, a trace of 4b was
formed in the above optimized conditions. This is due to the
high reactivity of the 3-position of 4-hydroxycoumarins. When
the reaction was carried out in the presence of a solvent, 4b was
obtained in a higher yield in comparison to the amount obtained
in solvent-free conditions. To examine the reusability of Mg(ClO4)2
under solvent-free conditions, after each run, the catalyst resi-
due was washed with hot CH2Cl2 and reused. The catalyst was
reusable although a gradual decline was observed in its activity
(Table 1, Entry 12).
We investigated the generality of this reaction by using,
dimedone 1, 4-hydroxycoumarin 2, and various aromatic alde-
hydes under the optimized conditions (Table 2).
Aromatic aldehydes containing electron-withdrawing groups
reacted very well with higher yields in a shorter time than
aromatic aldehydes with electron-donating groups (Table 2,
Entry 3, 12). Also, a,b-unsaturated aldehydes such as cinnam-
aldehyde were easily converted to the desired product under
the same experimental conditions, but in lower yields (Table 2,
Entry 14). Entries 4, 10, 12 and 14 in Table 2 are new compounds.
Finally, in order to assess the efficiency and generality of this
methodology, we compared this method with some reported
results in the literature. From comparison with the results
depicted in Table 3, it was found that Mg(ClO4)2 is the most effi-
cient catalyst with respect to reaction time, temperature and
yield of the product (Table 3).
It is clear from the results that our method compare better than
the best methods currently available in literature. Although the
mechanism of the reaction has not yet been established experi-
mentally, the formation of the product can be rationalized as
outlined in Scheme 1.
In summary, this paper reports a quick and efficient procedure
for the synthesis of tetrahydrochromeno[4,3-b]chromene-6,8-
dione derivatives via a one-pot three-component reaction. The
short reaction time, high yield, and availability of Mg(ClO4)2 as
a catalyst are the prominent features of this transformation.
Moreover, the experimental procedure for this reaction is
remarkably simple and without the use of hazardous or expen-
sive organic solvents.
3. Experimental
3.1. Materials and Instruments
The products were characterized by IR, 1H-, and 13C-NMR and
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by comparison of their physical properties with those reported
in the literature. IR spectra were recorded on a Bruker, Eqinox 55
spectrometer. 1H- and 13C-NMR spectra were obtained using
a Bruker Avance 400- and 500-MHz spectrometer (DRX). The
melting points were determined with a Buchi melting point
B-540 B.V.CHI apparatus.
3.2. General Procedure for the Synthesis of 10,11-Dihydro-
chromeno[4,3-b]chromene-6,8(7H,9H)-dione Derivatives
A mixture of dimedone (1 mmol, 0.14 g), 4-hydroxycoumarin
(1 mmol, 0.16 g), aldehyde (1 mmol) and Mg(ClO4)2 (0.18 mmol,
0.04 g) was heated under solvent-free conditions at 90 °C for an
appropriate time. After completion of the reaction, for isolation
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Table 1 Reaction of dimedone, 4-hydroxycoumarin and benzaldehyde under different conditions.a
Entry Catalyst/g) Temp/°C Solvent Time/min Yield/%
1 – 70 – 50 –
2 LiClO4 (0.01) 70 – 30 45
3 MgBr2 (0.03) 70 – 35 30
4 MgCl2 (0.02) 70 – 25 70
5 MgSO4 (0.02) 70 – 40 25
6 Mg(ClO4)2 (0.03) 70 – 25 70
7 Mg(ClO4)2 (0.03) 90 – 25 83
8 MgCl2 (0.02) 90 – 25 72
9 Mg(ClO4)2 (0.03) 110 – 25 85
10 Mg(ClO4)2 (0.01) 90 – 25 60
11 Mg(ClO4)2 (0.02) 90 – 25 75
12 b Mg(ClO4)2 (0.04) 90 – 25 93, 89, 85
13 Mg(ClO4)2 (0.05) 90 – 25 92
14 Mg(ClO4)2 (0.06) 90 – 25 93
15 Mg(ClO4)2 (0.04) Reflux n-Hexane 60 –
16 Mg(ClO4)2 (0.04) Reflux THF 60 20
17 Mg(ClO4)2 (0.04) Reflux MeC 60 30
18 Mg(ClO4)2 (0.04) Reflux EtOAc 60 40
19 Mg(ClO4)2 (0.04) Reflux CHCl3 60 50
20 Mg(ClO4)2 (0.04) Reflux H2O 60 55
21 Mg(ClO4)2 (0.04) Reflux EtOH 60 80
a Reaction conditions: dimedone (1 mmol), 4-hydroxycoumarin (1 mmol), benzaldehyde (1 mmol).
b Catalyst was recycled three times.
Scheme 1
The proposed mechanism of synthesizing 7-phenyl-tetrahydrochromeno[4,3-b]chromene-6,8-dione catalyzed by Mg(ClO4)2.
of catalyst the mixture was dissolved in hot CH2Cl2 and filtered.
The solvent of resulted filtrate was evaporated and the pure
product was obtained by recrystalization from ethanol. In Table
2, entries 4, 10, 12 and 14 are new tetrahydrochromeno[4,3-b]
chromene-6,8-dione derivatives. The IR and NMR spectra of
the new compounds are provided as supplementary material.
3.3. Spectroscopic Data
10,10-Dimethyl-7-phenyl-10,11-dihydrochromeno[4,3-b]chro-
mene-6,8(7H,9H)-dione (Table 2, Entry 1): M.p. 220–222 °C [7],
IR: 2960, 1711, 1664, 1604, 1490, 1452, 1364, 1324, 1288, 1182, 1164,
1051, 1031, 892, 764. 1H-NMR (500 MHz, CDCl3): 1.09 (s, 3 H); 1.11
(s, 3 H); 2.22 (d, J = 16.4 Hz, 2 H); 2.64 (d, J = 16.4 Hz, 2 H); 4.96 (s,
1 H); 7.17 (t, J = 7.4 Hz, 1 H); 7.25 (t, J = 7.4 Hz, 2 H); 7.29 (d, J =
7.6 Hz, 2 H); 7.37–7.44 (m, 2 H); 7.62 (t, J = 8.0 Hz, 1 H); 7.85 (dd,
J = 8.0 Hz, J = 1.8 Hz, 1 H). 13C-NMR (125 MHz, CDCl3): 27.2, 28.9,
32.0, 33.2 40.3, 50.9, 105.0, 114.2, 115.3, 115.9, 120.1, 123.2, 125.3,
127.6, 128.5, 131.2, 140.3, 153.3, 153.7, 161.9, 196.2.
10,10-Dimethyl-7-(3-nitrophenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 2): M.p. 230–232 °C [9],
IR: 2973, 1719, 1657, 1609, 1526, 1351, 1181, 1142, 1093, 1034, 1031,
818, 764. 1H-NMR (500 MHz, CDCl3): 1.10 (s, 3 H); 1.13 (s, 3 H);
2.24 (d, J = 16.0 Hz, 2 H); 2.41 (d, J = 16.4 Hz, 2 H); 4.99 (s, 1 H);
7.22 (t, J = 7.5 Hz, 1 H); 7.29 (d, J = 7.5 Hz, 1 H); 7.40 (d, J = 7.6 Hz,
2 H); 7.61–7.68 (m, 2 H); 7.88 (t, J = 7.8 Hz, 1 H); 8.05 (d, J = 7.8 Hz,
1 H). 13C-NMR (125 MHz, CDCl3): 28.3, 29.2, 30.5, 34.8, 39.4, 51.2
107.0, 113.4, 114.0, 115.6, 122.6, 124.0, 127.0, 128.2, 128.9, 130.9,
132.8, 136.4, 138.4, 149.5, 155.0, 163.2, 196.0.
10,10-Dimethyl-7-(4-nitrophenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 3): M.p. 208–210 °C [9],
IR: 2930, 1719, 1651, 1605, 1528, 1458, 1342, 1178, 1098, 1033, 863,
760. 1H-NMR (400 MHz, CDCl3): 1.10 (s, 3 H); 1.12 (s, 3 H); 2.18 (d,
J = 16.4 Hz, 1 H); 2.26 (d, J = 16.4 Hz, 1 H); 2.67 (d, J = 18.1 Hz,
1 H); 2.73 (d, J = 18.1 Hz, 1 H); 4.95 (s, 1 H); 6.90 (d, J = 8.8 Hz, 2 H);
7.04 (d, J = 8.8 Hz, 2 H); 7.34–7.40 (m, 2 H); 7.59 (t, J = 8.2 Hz, 1 H);
7.89 (dd, J = 8.2 Hz, J = 1.6 Hz 1 H). 13C-NMR (100 MHz, CDCl3):
27.3, 29.3, 31.2, 32.8, 40.8, 50.7, 114.8, 115.0, 115.1, 115.3, 115.5,
117.0, 122.5, 124.4, 129.8, 129.9, 130.2, 130.3, 132.4, 162.0, 162.3,
163.0, 196.5.
10,10-Dimethyl-7-(3-fluorophenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 4): M.p. 247–249 °C,
IR: 2957, 1720, 1664, 1607, 1362, 1260, 1175, 1054, 1030, 889, 766 .
1H-NMR (500 MHz, CDCl3): 1.14 (s, 3 H); 1.21 (s, 3 H), 2.32 (d, J =
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Table 2 Preparation of tetrahydrochromeno[4,3-b]chromene-6,8-diones under optimized conditions.a
Entry R Time/min Yield/% Ref.
1 C6H5 27 93 7
2 3-NO2C6H4 22 90 9
3 4-NO2C6H4 20 92 9
4 3-FC6H4 25 93 –
5 4-FC6H4 23 91 8
6 4-ClC6H4 23 89 9
7 4-MeC6H4 27 87 8
8 3-BrC6H4 25 90 10
9 4-OMeC6H4 30 88 7
10 3,4-(OMe)2C6H3 32 87 –
11 3-OHC6H4 37 85 7
12 4-OHC6H4 35 83 –
13 4-OH-3-OMeC6H3 32 85 7
14 C6H5CH=CH 40 78 –
15 2,4-Cl2C6H3 30 90 7
a Reaction conditions: dimedone (1 mmol), 4-hydroxycoumarin (1 mmol), aldehyde (1 mmol).
Table 3 Comparison of the efficiency of Mg(ClO4)2 with that of the reported catalysts for the synthesis of tetrahydrochromeno[4,3-b]chromene-
6,8-diones.
Entry Catalyst/mol% Solvent Temp/°C Time/min Yield/% Ref.
1 [DMDBSI]2HSO4
a /20 mol% H2O Reflux 240 93 7
2 Fe(DS)3
b /10 mol% H2O 70 120 87 8
3 p-TSA /5 mol% – 120 300 76 9
4 Mg(ClO4)2
c /18 mol% – 90 25 93 –
a Acid-functionalized ionic liquids [1,3-dimethyl-2-oxo-1,3-bis(4-sulfobutyl)imidazololidine-1,3-diium hydrogen sulfate].
b FeCl3/Sodium dodecyl sulfate.
cReaction conditions: dimedone (1 mmol),4-hydroxycoumarin (1 mmol), aldehyde (1 mmol).
16.5 Hz, 1 H); 2.37 (d, J = 16.5 Hz, 1 H); 2.70 (d, J = 16.5 Hz, 1 H);
2.77 (d, J = 18.5 Hz, 1 H); 5.01 (s, 1 H); 6.87–6.91 (m, 1 H); 7.08 (d,
J = 10.0 Hz, 1 H); 7.24–7.28 (m, 2 H); 7.37 (d, J = 8.5 Hz, 1 H); 7.42
(t, J = 8.0 Hz, 1 H); 7.62 (t, J = 7.5 Hz, 1H); 7.91 (dd, J = 8.0 Hz, J =
1.5 Hz, 2 H). 13C-NMR (100 MHz, CDCl3): 27.5, 29.8, 31.8, 32.6,
39.3, 50.9, 105.3, 115.2, 115.4, 123.3, 123.6, 123.7 128.1, 128.2, 131.0,
132.0, 143.3, 147.2, 147.9, 159.8, 161.3, 164.0, 196.4. Anal. calc. for
C24H19FO4 (390.40): C 73.84, H 4.91; found C 73.5, H 4.8.
10,10-Dimethyl-7-(4-chlorophenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 6): M.p. 248–250 °C [9],
IR: 2983, 1718, 1662, 1607, 1490, 1360, 1189, 1092, 1013, 895, 762.
1H-NMR (500 MHz, CDCl3): 1.02 (s, 3 H); 1.10 (s, 3 H); 2.20 (d, J =
16.0 Hz, 1 H); 2.33 (d, J = 15.5 Hz, 1 H); 2.73–2.82 (m, 2 H); 4.66 (s,
1 H); 7.01 (d, J = 8.0 Hz, 2 H); 7.12 (d, J = 8.0 Hz, 2 H); 7.46 (m, 2 H);
7.70 (t, J = 7.5 Hz, 1 H); 7.95 (d, J = 7.5 Hz, 1 H). 13C-NMR
(125 MHz, CDCl3): 27.5, 28.2, 30.7, 34.7, 39.5, 57.0, 105.9, 113.0,
116.6, 119.0, 122.5, 123.8, 124.7, 133.0, 135.5, 138.8, 148.2, 149.0,
152.2, 153.8 158.0, 162.9, 196.2.
10,10-Dimethyl-7-(4-methylphenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 7): M.p. 208–210 °C [8],
IR: 2957, 1714, 1666, 1605, 1562, 1453, 1353, 1307, 1265, 1192, 1034,
952, 762. 1H-NMR (500 MHz, CDCl3): 1.00 (s, 3 H); 1.09 (s, 3 H);
2.27 (d, J = 16.6 Hz, 2 H); 2.46 (d, J = 16.6 Hz, 2 H); 4.74 (s, 1 H);
7.31 (d, J = 8.0 Hz, 2 H); 7.40 (d, J = 8.0 Hz, 2 H); 7.52 (m, 2H); 7.75
(t, J = 8.0 Hz, 1H); 7.91 (dd, J = 8.1 Hz, J = 1.5 Hz, 1 H). 13C-NMR
(125 MHz, CDCl3): 28.2, 28.4, 29.7, 33.0, 38.9, 52.2, 105.1, 111.2,
114.9, 116.6, 124.2, 125.8, 126.2, 130.8, 136.9, 137.1, 141.2, 148.5,
152.4, 155.1, 157.3, 161.9, 196.1.
10,10-Dimethyl-7-(3-bromophenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 8): M.p. 258–260 °C
[10], IR: 2970, 1719, 1664, 1607, 1568, 1454, 1360, 1185, 1140, 1054,
1050, 1034, 755. 1H-NMR (500 MHz, CDCl3): 1.30 (s, 3 H), 1.19 (s,
3 H), 2.29 (d, J = 16.8 Hz, 1 H); 2.35 (d, J = 16.4 Hz, 1 H); 2.67 (d, J =
17.1 Hz, 1 H); 2.76 (d, J = 17.1 Hz, 1 H); 4.94 (s, 1 H); 7.16 (t, J =
8.0 Hz, 1 H); 7.28–7.43 (m, 5 H); 7.61 (t, J = 7.6 Hz, 1 H); 7.90 (dd,
J = 8.0 Hz, J=1.2 Hz,1 H). 13C-NMR (125 MHz, CDCl3): 27.6, 29.1,
32.4, 33.3, 40.8, 50.7, 106.1, 113.7, 114.7, 117.0, 122.4, 128.0, 129.8,
130.3, 131.3, 132.5, 144.7, 150.0, 154.1, 160.6, 162.3, 195.9.
10,10-Dimethyl-7-(4-methoxyphenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 9): M.p. 187–189 °C [7],
IR: 2957, 1725, 1660, 1606, 1509, 1456, 1359, 1302, 1250, 1183, 1167,
1140, 1033, 893, 764. 1H-NMR (500 MHz, CDCl3): 1.14 (s, 3 H); 1.17
(s, 3 H); 2.21 (m, 2 H); 2.39 (m, 2 H); 4.85 (s, 1 H); 7.24 (d, J = 7.5 Hz,
2 H); 7.43 (d, J = 7.5 Hz, 2 H); 7.55 (m, 2 H); 7.79 (t, J = 8.0 Hz, 1 H);
7.98 (d, J = 8.0 Hz, 1 H). 13C-NMR (125 MHz, CDCl3): 27.0, 27.2,
28.4, 30.1, 37.0, 54.5, 106.3, 114.0, 114.1, 115.2, 123.0, 123.8, 128.3,
135.9, 136.2, 138.2, 143.9, 150.8, 153.1, 156.8, 158.1, 161.0, 195.9.
10,10-Dimethyl-7-(3,4-dimethoxyphenyl)-10,11-dihydrochromeno[4,
3-b]chromene-6,8(7H,9H)-dione (Table 2, Entry 10): M.p.
184–185 °C, IR: 2921, 1721, 1660, 1620, 1513, 1455, 1361, 1262, 1139,
896, 742. 1H-NMR (400 MHz, CDCl3): 1.13 (s, 3 H); 1.19 (s, 3 H);
2.30 (d, J = 16.0 Hz, 1 H); 2.35 (d, J = 16.0 Hz, 1 H); 2.68 (d, J =
17.6 Hz, 1 H); 2.74 (d, J = 17.6 Hz, 1 H); 3.81 (s, 3 H); 3.89 (s, 3 H);
4.93 (s, 1 H); 6.74 (d, J = 8.1 Hz, 1 H); 6.82 (dd, J = 8.0 Hz, J=1.6 Hz,
1 H); 7.05 (s, 1 H); 7.33–7.39 (m, 2 H); 7.58 (t, J = 8.0 Hz, 1 H); 7.88
(d, J = 8.0 Hz, 1 H). 13C-NMR (100 MHz, CDCl3): 27.5, 29.3, 32.4,
32.8, 40.9, 50.7, 106.9, 110.9, 112.7, 113.7, 115.2, 116.9, 120.2, 122.4,
124.3, 132.2, 135.4, 148.0, 148.6, 152.6, 153.7, 160.7, 161.9, 196.2.
Anal. calc. for C26H24O6 (432.47): C 72.21, H 5.59; found C 72.0,
H 5.8.
10,10-Dimethyl-7-(3-hydroxyphenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 11): M.p. 267–269 °C
[7], IR: 3400, 2983, 1697, 1665, 1607, 1488, 1364, 1175, 1137, 1058,
897, 767. 1H-NMR (500 MHz, DMSO-d6): 1.00 (s, 3 H); 1.10 (s, 3 H);
2.75 (sbr, 2 H); 2.37 (d, J = 16.5 Hz, 1 H); 4.62 (s, 1H); 6.55 (dd, J =
7.5 Hz, J = 2.1 Hz, 1 H); 6.66 (d, J = 7.0 Hz, 1 H); 6.71 (s, 1 H); 7.03
(t, J = 8.0 Hz, 1 H); 7.44 (d, J = 8.5 Hz, 1 H); 7.46 (t, J = 7.0 Hz, 1H);
7.69 (t, J = 7.5 Hz, 1 H); 7.93 (dd, J = 7.5 Hz, J = 1.5 Hz, 1 H); 9.29 (s,
1H). 13C-NMR (125 MHz, DMSO-d6): 27.6, 29.4, 32.9, 33.6, 50.9,
106.8, 114.0, 114.7, 114.8, 116.4, 117.4, 119.7, 123.4, 125.6, 129.9,
133.7, 145.0, 152.8, 154.5, 158.0, 163.4, 196.7.
10,10-Dimethyl-7-(4-hydroxyphenyl)-10,11-dihydrochromeno[4,3-b]
chromene-6,8(7H,9H)-dione (Table 2, Entry 12): M.p. 267–268 °C,
IR: 3431, 1697, 1665, 1607, 1585, 1488, 1364, 1176, 897, 767.
1H-NMR (400 MHz, DMSO-d6): 1.03 (s, 3 H); 1.09 (s, 3 H); 2.18 (d,
J = 16.6 Hz, 2 H); 2.33 (d, J = 16.6 Hz, 2 H); 4.60 (s, 1H); 6.62 (d, J =
8.6 Hz, 2 H); 7.05 (d, J = 8.6 Hz, 2 H); 7.46 (m, 2 H); 7.70 (t, J =
7.6 Hz, 1 H); 7.94 (t, J = 7.6 Hz, 1 H); 9.29 (s, 1 H). 13C-NMR
(100 MHz, DMSO-d6): 26.7, 28.5, 31.9, 32.0, 39.5, 50.0, 106.2, 113.2,
114.1, 114.8, 116.5, 122.5, 124.7, 129.3, 132.7, 133.3, 151.9, 153.3,
156.1, 159.9, 162.3, 195.9. Anal. calc. for C24H20O5 (388.41): C 74.21,
H 5.19; found C 73.9, H 5.0.
10,10-Dimethyl-7-(4-hydroxy-3-methoxyphenyl)-10,11-dihydrochro
meno[4,3-b]chromene-6,8(7H,9H)-dione (Table 2, Entry 13): M.p.
271–273 °C [7], IR: 3434, 2993, 1713, 1662, 1608, 1514, 1361, 1272,
1181, 1033, 863, 779. 1H-NMR (400 MHz, DMSO-d6): 1.02 (s, 3 H);
1.10 (s, 3 H); 2.20 (d, J = 16.0 Hz, 1 H); 2.34 (d, J = 16.0 Hz, 1 H);
2.76 (s, 2H), 3.70 (s, 3H); 4.61 (s, 1H); 6.61 (d, J = 8.0 Hz, 1 H); 6.64
(d, J = 8.0 Hz, 1 H); 6.81 (d, J = 1.6 Hz, 1 H); 7.43–7.48 (m, 2 H); 7.69
(t, J = 7.8 Hz, 1 H); 7.92 (d, J = 8.0 Hz, 1 H); 8.88 (s, 1 H). 13C-NMR
(100 MHz, DMSO-d6): 26.5, 28.6, 31.9, 32.2, 39.6, 50.0, 55.6, 106.1,
112.8, 113.2, 114.0, 115.1, 116.5, 120.5, 122.5, 124.7, 132.6, 133.8,
145.5, 147.0, 151.8, 153.3, 160.0, 162.4, 196.0.
10,10-Dimethyl-7-styryl-10,11-dihydrochromeno[4,3-b]chromene-6,
8(7H,9H)-dione (Table 2, Entry 14): M.p. 132–134 °C, IR: 2956,
1713, 1661, 1609, 1453, 1361, 1239, 1173, 1138, 1032, 970, 762, 696.
1H-NMR (400 MHz, CDCl3):1.10 (s, 3 H); 1.12 (s, 3 H); 2.36 (s, 2 H);
2.53 (d, J = 16.8 Hz, 1 H); 2.62 (d, J = 16.8 Hz, 1 H); 4.56 (br s, 1 H);
6.22 (dd, J = 16.0 Hz, J = 6.4, 1 H); 6.32 (d, J = 16.0 Hz, 1 H); 7.09 (t,
J =7.2 Hz, 1 H); 7.14–7.23 (m, 4 H); 7.26–7.31 (m, 2 H); 7.51 (t, J =
8.0 Hz, 1 H); 7.76 (d, J = 7.2 Hz, 1 H). 13C-NMR (100 MHz, CDCl3):
27.6, 29.0, 32.2, 33.5, 40.9, 50.8, 107.1, 116.9, 122.4, 124.3, 126.4,
126.5, 127.5, 128.3, 128.4, 129.5, 131.8, 132.3, 147.6, 162.1, 165.0,
166.9, 196.6. Anal. calc. for C32H26O4 (474.55): C 80.99, H 5.52;
found C 81.3, H 5.8.
10,10-Dimethyl-7(2,4-dichlorophenyl)-10,11-dihydrochromeno[4,3-b
]chromene-6,8(7H,9H)-dione (Table 2, Entry 15): M.p. 250–252 °C
[7], IR: 2956, 1716, 1664, 1611, 1583, 1470, 1360, 1265, 1173, 1061,
1052, 832, 753. 1H-NMR (400 MHz, CDCl3): 1.08 (s, 3 H), 1.12 (s,
3 H); 2.22 (d, J = 16.0 Hz, 1 H); 2.28 (d, J = 16.0 Hz, 1 H); 2.69 (s,
2 H); 4.92 (s, 1 H); 7.01 (d, J = 8.0 Hz, 1 H); 7.13 (d, J = 8.0 Hz, 1 H);
7.30 (s, 1 H); 7.39–7.49 (m, 2 H); 7.69 (t, J = 7.6 Hz, 1 H); 7.98 (d, J =
7.8 Hz, 1 H). 13C-NMR (100 MHz, CDCl3): 28.0, 28.9, 31.9, 33.1,
40.9, 52.3, 107.2, 112.2, 114.8, 115.1, 116.0, 118.2, 123.9, 124.1, 124.3,
135.4, 137.9, 144.2, 150.0, 151.0, 156.9, 158.3, 160.9, 195.0.
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